Jun 29, 2005 by Stephen D. SimpsonCardioDynamics Needs Growth, Stat!CardioDynamics no longer deserves the benefit of the doubt until it produces some growth.
Jun 29, 2005 by Stephen D. SimpsonFeast or Famine at MonsantoDisappointing guidance will hurt the stock, but the business still seems quite good.
Jun 29, 2005 by Stephen D. SimpsonAIG's Road to RecoveryIf AIG continues to deliver solid financial results, investors will quickly forget the problems.
Jun 29, 2005 by Stephen D. SimpsonNet2Phone HomeIDT bids for the remainder of Net2Phone's common stock.
Jun 29, 2005 by Stephen D. SimpsonCalpine Does It AgainCalpine has been creative and resourceful in disposing of assets for much-needed cash.
Jun 29, 2005 by Stephen D. SimpsonBassett Is No DogDespite being in the furniture business, Bassett is holding its own and paying a decent dividend.
Jun 29, 2005 by Stephen D. SimpsonMedtronic Makes a Fat DealMedtronic's purchase of the developer of an "obesity pacemaker" could reap rewards in a few years.
Jun 29, 2005 by Stephen D. SimpsonSymbol Technologies Gets TaggedWhile the RFID market is indeed promising, the company needs to shore up the present.
Jun 29, 2005 by Stephen D. SimpsonLove in the Pits?Rumors say the Chicago Merc wants to buy the Chicago Board of Trade before CBOT goes public.
Jun 29, 2005 by Stephen D. SimpsonWhat's Cooking in Kazakhstan?As PetroKazakhstan entertains buyout offers, its namesake's government steps in.
Jun 28, 2005 by Stephen D. SimpsonInternational Paper WrinklesHigh costs and sluggish demand take a bite out of this massive paper maker.
Jun 28, 2005 by Stephen D. SimpsonApollo's CreedApollo Group has the goods in terms of growth, but these shares don't come cheap.
Jun 28, 2005 by Stephen D. SimpsonA Boost for WyethWyeth raises full-year expectations for the second time.
Jun 27, 2005 by Stephen D. SimpsonSniffing Out a Possible Diabetes BlockbusterInhaled insulin has been a Holy Grail of diabetes care. Will it live up to lofty expectations?
Jun 24, 2005 by Stephen D. SimpsonBlurry OmniVisionDespite management enthusiasm, the semiconductor company's picture isn't getting any clearer.
Jun 24, 2005 by Stephen D. SimpsonIs Rite Aid a Real Value Stock?Reality hasn't caught up with the company's turnaround prospects.
Jun 24, 2005 by Stephen D. SimpsonThe Ballard Power BalletA long-awaited agreement is finally signed that should cut cash consumption.
Jun 24, 2005 by Stephen D. SimpsonDiamondCluster Gets Cluster-BombedPushed-back business and high taxes lead to an earnings miss.
Jun 24, 2005 by Stephen D. SimpsonShould Investors Select Solectron?Solectron has survived the tech wreck, and better days could be ahead.
Jun 23, 2005 by Stephen D. SimpsonDueling Fools: Merck BearWhy buy a troubled pharma company when better options exist?
